These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 2932380)

  • 1. Hepatitis A and B in non-institutionalized mentally retarded patients.
    Renner F; Andrle M; Horak W; Rett A
    Hepatogastroenterology; 1985 Aug; 32(4):175-7. PubMed ID: 2932380
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hepatitis and Down's syndrome.
    Madden DL; Matthew EB; Dietzman DE; Purcell RH; Sever JL; Rostafinski M; Mata A
    Am J Ment Defic; 1976 Jan; 80(4):401-6. PubMed ID: 129005
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hepatitis B virus infection among mentally retarded patients in institutions, Okinawa, Japan.
    Hayashi J; Kashiwagi S; Noguchi A; Nakashima K; Ikematsu H; Kajiyama W; Nomura H
    Fukuoka Igaku Zasshi; 1989 Sep; 80(9):436-40. PubMed ID: 2807128
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Occurrence of hepatitis B and C among mentally retarded].
    Lunding S; Hansen KS; Krogsgaard K; Rosdahl N; Smith E; Wantzin PS
    Ugeskr Laeger; 1999 Aug; 161(31):4393-6. PubMed ID: 10487103
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Hepatitis B markers at 3 open centers for mentally retarded].
    Devesa F; Martínez F; Moreno MJ; Sanfrancisco M; Ferrando J; Rull S
    Rev Esp Enferm Dig; 1993 Sep; 84(3):162-8. PubMed ID: 8217381
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Mentally deficient patients and infection caused by hepatitis B virus. Prevalence in our area].
    García Bengoechea M; Legarda JJ; Cortés A; Enríquez I; Arriola JA; Arenas JI
    Med Clin (Barc); 1989 Jun; 93(1):10-3. PubMed ID: 2528041
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lymphocyte surface markers and serum immunoglobulins in persons with Down's syndrome.
    Hann HW; Deacon JC; London WT
    Am J Ment Defic; 1979 Nov; 84(3):245-51. PubMed ID: 160754
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Hepatitis B at an open institution for the mentally retarded. Immunogenic effect of a recombinant anti-hepatitis-B vaccine].
    García O; Bruguera M; Mayor A; Sánchez-Tapias JM; Vall O; Rodés J
    Enferm Infecc Microbiol Clin; 1990 Mar; 8(3):148-52. PubMed ID: 2151250
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Study on the control of hepatitis B virus infection in an institution for the mentally retarded.
    Broggini M; Maggiolo F; Bianchi E; Torre D
    Boll Ist Sieroter Milan; 1983; 62(6):495-500. PubMed ID: 6234005
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Predisposition of Down syndrome to chronic infection with the hepatitis B virus].
    Rua Armesto MJ; Ramírez Marín V; Onaindia Ercoreca MT; García Aguado J; Ruiz Moreno M
    An Esp Pediatr; 1993 Jun; 38(6):529-31. PubMed ID: 8368682
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antibody to hepatitis B antigen (Australia antigen) among residents of a Finnish institution for the mentally retarded.
    Tevaluoto-Aarnio M; Werner B; London WT
    Med Biol; 1975 Feb; 53(1):51-9. PubMed ID: 124806
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hepatitis B vaccination in Down's syndrome and other mentally retarded patients.
    Heijtink RA; De Jong P; Schalm SW; Masurel N
    Hepatology; 1984; 4(4):611-4. PubMed ID: 6235163
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hepatitis-B surface antigen and antibody: prevalence and persistence in institutionalized and noninstitutionalized persons.
    McMillan BC; Hanson RP; Golubjatnikov R; Sinha SK
    Public Health Rep; 1979 Jun; 94(3):262-7. PubMed ID: 156381
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Hepatitis B (HBV) and C (HBC) virus infections in Down's syndrome and in neuropsychiatric patients without Down's syndrome].
    Findor JA; Sordá JA; Rey J; Fernández J; Kohan A; Díaz Lestrem M
    G E N; 1992; 46(3):208-12. PubMed ID: 1340826
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hepatitis B infection in institutionalized Down's syndrome inmates: a longitudinal study with five hepatitis B virus markers.
    Hawkes RA; Boughton CR; Schroeter DR; Decker RH; Overby LR
    Clin Exp Immunol; 1980 Jun; 40(3):478-86. PubMed ID: 6448112
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hepatitis B surface antigen and its subtypes in an institution for the mentally retarded.
    Perry E; Chaudhary RK; Cleary TE; Roughley FR
    Can Med Assoc J; 1975 Jan; 112(1):46-8. PubMed ID: 122813
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Vertical hepatitis B transmission in the Vienna area: epidemiologic and clinical studies].
    Sacher M
    Wien Klin Wochenschr Suppl; 1985; 164():3-18. PubMed ID: 3865474
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The antibody response of institutionalized Down's syndrome patients to seven microbial antigens.
    Hawkes RA; Boughton CR; Schroeter DR
    Clin Exp Immunol; 1978 Feb; 31(2):298-304. PubMed ID: 148342
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hepatitis B virus infection in an institution for the mentally retarded.
    van Ditzhuijsen TJ; de Witte-van der Schoot E; van Loon AM; Rijntjes PJ; Yap SH
    Am J Epidemiol; 1988 Sep; 128(3):629-38. PubMed ID: 2970793
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hepatitis B in a Belgian institution for mentally retarded patients: an epidemiological study.
    Devuyst O; Maesen-Collard Y
    Acta Gastroenterol Belg; 1991; 54(1):12-8. PubMed ID: 2058345
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.